Free Trial
ASX:CT1

Constellation Technologies (CT1) Stock Price, News & Analysis

Constellation Technologies logo

About Constellation Technologies Stock (ASX:CT1)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
983,646 shs
Average Volume
N/A
Market Capitalization
A$1.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CT1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Constellation Technologies and its competitors with MarketBeat's FREE daily newsletter.

CT1 Stock News Headlines

Did you miss out on Trump’s “birthday gift” to Americans?
While protestors were rallying against “King Trump,” one trader quietly spotted a 15% weekend move tied to his actions. This setup is part of a larger pattern — one that repeats whenever Trump makes waves. Now, veteran trader Larry Benedict is revealing three “Trigger Tickers” that could deliver 2–3X returns… plus a $194 trillion catalyst that could light up the markets.
Constellation Technologies Limited
See More Headlines

CT1 Stock Analysis - Frequently Asked Questions

Constellation Technologies Limited (ASX:CT1) posted its quarterly earnings results on Thursday, February, 28th. The company reported $0.00 earnings per share (EPS) for the quarter. Constellation Technologies had a negative trailing twelve-month return on equity of 13.35% and a negative net margin of 9.04%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Constellation Technologies investors own include Neuren Pharmaceuticals (NEU), Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO) and Dreadnought Resources (DRE).

Company Calendar

Last Earnings
2/28/2019
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Information Technology Services
Sub-Industry
N/A
Current Symbol
ASX:CT1
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$1.35 million
Price / Cash Flow
5.63
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,470,000,000
Free Float
N/A
Market Cap
A$1.47 million
Optionable
Not Optionable
Beta
1.40
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:CT1) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners